UnknownPhase 3NCT01125644

Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Proaparts srl
Principal Investigator
Luigi Allegra, Ph.D.
Ospedale Maggiore di Milano IRCCS Policlinico
Intervention
SPK-843(drug)
Enrollment
10 enrolled
Eligibility
18-75 years · All sexes
Timeline
20102011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01125644 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials